117 related articles for article (PubMed ID: 6230421)
1. Methyl-CCNU, 5-fluorouracil, vincristine, and streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma.
Weltz MD; Perry DJ; Blom J; Butler WM
J Clin Oncol; 1983 Feb; 1(2):135-7. PubMed ID: 6230421
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380
[TBL] [Abstract][Full Text] [Related]
3. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group study.
Engstrom PF; MacIntyre JM; Schutt AJ; Douglass HO
Am J Clin Oncol; 1985 Oct; 8(5):358-61. PubMed ID: 2932908
[TBL] [Abstract][Full Text] [Related]
5. Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1980 Mar; 45(5):876-81. PubMed ID: 7260839
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma.
Kemeny N; Reichman B; Geller N; Hollander P
Am J Clin Oncol; 1988 Feb; 11(1):66-72. PubMed ID: 2963534
[TBL] [Abstract][Full Text] [Related]
7. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
8. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate.
Craig JB; Jackson DV; Richards FR; Muss HB; White DR; Cooper MR; Stuart JJ; Spurr CL
Am J Clin Oncol; 1987 Feb; 10(1):44-6. PubMed ID: 3825991
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
Kemeny N; Yagoda A; Braun D; Golbey R
Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with 5-fluorouracil, CCNU, and vincristine in metastatic colorectal carcinoma.
Xavier AM; Kasimis BS; Wu SY; Kaneshiro CA
Am J Clin Oncol; 1984 Oct; 7(5):513-5. PubMed ID: 6391144
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
Roth A; Kolarić K
Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
[No Abstract] [Full Text] [Related]
14. Systemic cytostatic drug therapy in liver cancer.
Glimelius B
Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
Joss RA; Goldberg RS; Yates JW
Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
[TBL] [Abstract][Full Text] [Related]
16. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
17. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
[TBL] [Abstract][Full Text] [Related]
18. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
Cantrell JE; Hart RD; Taylor RF; Harvey JH
Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
[TBL] [Abstract][Full Text] [Related]
19. Sequential methotrexate and 5-fluorouracil: improved response rate in metastatic colorectal cancer.
Herrmann R; Spehn J; Beyer JH; von Franqué U; Schmieder A; Holzmann K; Abel U
J Clin Oncol; 1984 Jun; 2(6):591-4. PubMed ID: 6327928
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
